Calcineurin B stimulates cytokine production through a CD14-independent Toll-like receptor 4 pathway

Immunology and Cell Biology

Volumn 94, Issue 3, 2016, Pages 285-292

  Wu, Wu ^a   Chen, Qing ^a   Geng, Feng ^a   Tong, Li ^a   Yang, Rui ^a   Yang, Jinju ^a   Zhang, Hongwei ^a   Jia, Zongchao ^a,b   Wei, Qun ^a  

^a BEIJING NORMAL UNIVERSITY   (China)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; CALCINEURIN B; CD14 ANTIGEN; CYTOKINE; I KAPPA B KINASE ALPHA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG; I KAPPA B KINASE;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; BIOSYNTHESIS; CELL LINE; METABOLISM; MONONUCLEAR CELL; PHOSPHORYLATION;

ANTIGENS, CD14; CALCINEURIN; CELL LINE; CYTOKINES; ENDOCYTOSIS; HUMANS; I-KAPPA B KINASE; LEUKOCYTES, MONONUCLEAR; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 3; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4;

EID: 84961159478     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2015.91     Document Type: Article

References (27)

1. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 2004; 4: 469-478.
2. Zhong B, Tien P, Shu HB. Innate immune responses: crosstalk of signaling and regulation of gene transcription. Virology 2006; 352: 14-21.
3. Hacker H, Redecke V, Blagoev B, Kratchmarova I, Hsu LC, Wang GG, et al. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 2006; 439: 204-207.
4. Griffith JP, Kim JL, Kim EE, Sintchak MD, Thomson JA, Fitzgibbon MJ, et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12- FK506 complex. Cell 1995; 82: 507-522.
5. Milan D, Griffith J, Su M, Price ER, McKeon F. The latch region of calcineurin B is involved in both immunosuppressant-immunophilin complex docking and phosphatase activation. Cell 1994; 79: 437-447.
6. Parry RV, June CH. Calcium-independent calcineurin regulation. Nat Immunol 2003; 4: 821-823.
7. Dadley-Moore D. Thymocyte development: positive about calcineurin. Nat Rev Immunol 2004; 4: 318.
8. Dunn SE, Simard AR, Prud'homme RA, Michel RN. Calcineurin and skeletal muscle growth. Nat Cell Biol 2002; 4: E46.
9. Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR, et al. Calcineurin/ NFAT signalling regulates pancreatic beta-cell growth and function. Nature 2006; 443: 345-349.
10. Ladner CJ, Czech J, Maurice J, Lorens SA, Lee JM. Reduction of calcineurin enzymatic activity in Alzheimer's disease: correlation with neuropathologic changes. J Neuropathol Exp Neurol 1996; 55: 924-931.
11. Padma S, Sowjanya AP, Poli UR, Jain M, Rao B, Ramakrishna G. Downregulation of calcineurin activity in cervical carcinoma. Cancer Cell Int 2005; 5: 7.
12. Tang W, Arnett DK, Devereux RB, Panagiotou D, Province MA, Miller MB, et al. Identification of a novel 5-base pair deletion in calcineurin B (PPP3R1) promoter region and its association with left ventricular hypertrophy. Am Heart J 2005; 150: 845-851.
13. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006; 7: 589-600.
14. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 1992; 89: 3686-3690.
15. Graef IA, Chen F, Chen L, Kuo A, Crabtree GR. Signals transduced by Ca(2 +)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001; 105: 863-875.
16. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002; 109: S67-S79.
17. Padma S, Subramanyam C. Extracellular calcineurin: identification and quantitation in serum and amniotic fluid. Clin Biochem 1999; 32: 491-494.
18. Bindu LH, Rani PU, Reddy PP. Calcineurin activity in children with Mental handicap. Indian J Clin Biochem 2007; 22: 32-35.
19. Padma S, Subramanyam C. Clinical significance of serum calcineurin in acute leukemia. Clin Chim Acta 2002; 321: 17-21.
20. Sankaranarayanan TK, Sethi BK, Subramanyam C. Serum calcineurin activity in relation to oxidative stress and glycemic control in type II diabetes mellitus. Clin Biochem 2005; 38: 218-222.
21. Sundaram JS, Rao VM, Meena AK, Anandaraj MP. Decreased calcineurin activity in circulation of Duchenne muscular dystrophy. Clin Biochem 2007; 40: 443-446.
22. Kang YJ, Kusler B, Otsuka M, Hughes M, Suzuki N, Suzuki S, et al. Calcineurin negatively regulates TLR-mediated activation pathways. J Immunol 2007; 179: 4598-4607.
23. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998; 16: 225-260.
24. Wu W, Jia Z, Liu P, Xie Z, Wei Q. A novel PCR strategy for high-efficiency, automated site-directed mutagenesis. Nucleic Acids Res 2005; 33: e110.
25. Chen Q, Wu W, Li J, Wei Q. The polarity of the amino acid residue 118 of calcineurin B is closely linked to calcineurin enzyme activity. IUBMB Life 2010; 62: 561-567.
26. Diehn M, Eisen MB, Botstein D, Brown PO. Large-scale identification of secreted and membrane-associated gene products using DNA microarrays. Nat Genet 2000; 25: 58-62.
27. Wei Q, Lian ML, Jing FZ, Zhang N, Yan MS, Chen Y, et al. Studies of calcineurin B subunit from genetic engineering for use in medicine. Drug Dev Res 2002; 56: 40-43.